IPOs this week : March 11 - 15, 2019

IPO activity: The six-month lockup on shares of Nio (NYSE:NIO) expires on March 11 in what should be a good test of investor sentiment. Nio soared following a positive 60 Minutes piece about two weeks ago before going into post-earnings skid. Interestingly, Goldman Sachs came in with a reinstated Buy call on Nio ahead of the lockup expiration as it pointed to the Chinese automaker's "successful branding" in the premium segment.

Other lockup expirations this week include;

• 111 (NASDAQ:YI) on March 11, 
• FVC Bancorp (NASDAQ:FVCB) on March 12 and 
• both Principia Biopharma (NASDAQ:PRNB) and Qutoutiao (NASDAQ:QTT) on March 13. 

Analysts can start covering TCR2 Therapeutics (NASDAQ:TCRR), Avedro (NASDAQ:AVDR), Achiano Therapeutics (NASDAQ:ANCN) and Imac (NASDAQ:IMAC) on March 11 and Stealth BioTherapeutics (NASDAQ:MITO) on March 12.

IPOs this week : Feb. 11 - 15, 2019

IPOs expected to price:

• Anchiano Therapeutics (ANCN) on February 11; 
• Virgin Trains USA (VTUS) on February 12; 
• TCR2 Therapeutics (TCRR), 
• Cibus (CBUS) and Avedro (AVDR) on February 13; 
• Stealth BioTherapeutics (MITO) on February 14.

IPO activity: In case you missed it, the IPO market was lit up with the news that Postmates (POSTM) and Slack (SLACK) filed for confidential listings.

There are IPO share lock-up expirations upcoming on Avalon GloboCare (OTCQB:AVCO) and Aridis Pharmaceuticals (NASDAQ:ARDS) on February 12 and Safe-T (NASDAQ:SFET) on February 13.